Cancer Epidemiology, Biomarkers & Prevention
Abbreviated title (ISO 4) | Cancer Epidemiol. Biomarkers Prev. |
|---|---|
| Discipline | Cancer epidemiology |
| Language | English |
| Edited by | Timothy R. Rebbeck |
| Publication details | |
| Publisher | |
Publication history | 1991-present |
| Frequency | monthly[1] |
| 4.125 | |
| Indexing | |
| ISSN |
1055-9965 (print) 1538-7755 (web) |
| CODEN | CEBPE4 |
| OCLC no. | 23441645 |
| Links | |
Cancer Epidemiology, Biomarkers & Prevention is a peer-reviewed medical journal devoted to research in the field of cancer epidemiology. Topics include descriptive, analytical, biochemical, and molecular epidemiology, the use of biomarkers to study the neoplastic and preneoplastic processes in humans, chemoprevention and other types of prevention trials, and the role of behavioral factors in cancer etiology and prevention.
Indexed by ISI Cancer Epidemiology, Biomarkers & Prevention collected an impact factor of 4.125 as reported in the 2014 Journal Citation Reports by Thomson Reuters, ranking it 53 out of 211 journals in the category Oncology [2] and ranking it 17 out of 162 journals in the category Public, environmental & occupational health.[3]
References
- ↑ Reuters Master Journal List accessed Dec 03, 2009
- ↑ "Journals Ranked by Impact: Oncology". 2014 Journal Citation Reports. Web of Science (Sciences ed.). Thomson Reuters. 2015.
- ↑ "Journals Ranked by Impact: Public, environmental & occupational health". 2014 Journal Citation Reports. Web of Science (Sciences ed.). Thomson Reuters. 2015.